|

Topotecan Hydrochloride Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Evotopin, Hycamptamine, Hycamtin, Nogitecan Hydrochloride, Potactasol +6 more

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Children's Oncology Group1

Indications

  • Cancer2
  • Ganglioneuroblastoma, Nodular1
  • Ganglioneuroblastoma1
  • Recurrent Lung Small Cell Carcinoma1
  • Recurrent Extensive Stage Lung Small Cell Carcinoma1

Birmingham, Alabama1 trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Children's Hospital of Alabama

Phase 3

Los Angeles, California1 trial

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Keck Medicine of USC Koreatown

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.